Sebelipase alfa
Kanuma (sebelipase alfa) is an enzyme pharmaceutical. Sebelipase alfa was first approved as Kanuma on 2015-08-28. It has been approved in Europe to treat inborn errors lipid metabolism.
| Trade Name | Kanuma |
|---|---|
| Common Name | Sebelipase alfa |
| Indication | inborn errors lipid metabolism |
| Drug Class | Enzymes |
